Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05585320 |
|---|---|
| Brief Title: | A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors |
| First Submitted : | October 14, 2022 |
| First Submitted that Met QC Criteria : | October 14, 2022 |
| First Posted : | October 18, 2022 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |